Steve Martin
2016 - AmpliPhi Biosciences
In 2016, Steve Martin earned a total compensation of $615K as Senior VP and Chief Financial Officer at AmpliPhi Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $67,200 |
|---|---|
| Option Awards | $239,801 |
| Salary | $306,667 |
| Other | $1,341 |
| Total | $615,009 |
Martin received $306.7K in salary, accounting for 50% of the total pay in 2016.
Martin also received $67.2K in non-equity incentive plan, $239.8K in option awards and $1.3K in other compensation.
Rankings
In 2016, Steve Martin's compensation ranked 10,442nd out of 14,075 executives tracked by ExecPay. In other words, Martin earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,442 out of 14,075 | 26th |
Division Manufacturing | 4,031 out of 5,486 | 27th |
Major group Chemicals And Allied Products | 1,425 out of 1,900 | 25th |
Industry group Drugs | 1,142 out of 1,543 | 26th |
Industry Biological Products, Except Diagnostic Substances | 201 out of 287 | 30th |
Source: SEC filing on July 24, 2017.
Martin's colleagues
We found three more compensation records of executives who worked with Steve Martin at AmpliPhi Biosciences in 2016.